{
  "type": "hyp",
  "text": "We found positive Bcl-xL Bax and p53 immunostaining in 44.5% 28.6% and 58.9% of the studied primary tumors and in 63.6% 45.5% and 72.7% of lymph node metastases respectively.\n",
  "self": {
    "NER": {
      "answers": [
        "Bcl-xL",
        "44.5%",
        "28.6%",
        "58.9%",
        "63.6%",
        "45.5%",
        "72.7%"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What type of antibody was found in 58.9% of primary tumors?",
          "What percentage of primary tumors were positive for Bcl-xL Bax and",
          "What percentage of primary tumors were positive for Bcl-xL Bax and",
          "What percentage of primary tumors were positive for Bcl-xL Bax and",
          "What percentage of primary tumors were positive for Bcl-xL Bax and",
          "What percentage of primary tumors were positive for Bcl-xL Bax and",
          "What percentage of lymph node metastases were positive for Bcl-xL Ba"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "We",
        "positive Bcl-xL Bax",
        "p53",
        "44.5%",
        "the studied primary tumors",
        "63.6%",
        "45.5%",
        "72.7%"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was the percentage of primary tumors that had Bcl-xL Bax and",
          "What immunostaining was found in 58.9% of primary tumors?",
          "What immunostaining was found in 58.9% of primary tumors?",
          "What percentage of primary tumors were positive for Bcl-xL Bax and",
          "What percentage of lymph nodes were positive for Bcl-xL Bax and",
          "What percentage of primary tumors were positive for Bcl-xL Bax and",
          "What percentage of primary tumors were positive for Bcl-xL Bax and",
          "What percentage of lymph node metastases were positive for Bcl-xL Ba"
        ]
      }
    }
  },
  "asked": {
    "What was significantly reduced in lymph node metastases?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005903363227844238,
        "ground_truth": {
          "CD82 expression": {
            "bertscore": 0.6479768753051758,
            "f1": 0
          }
        }
      }
    },
    "What type of cancers were the effects of CD82?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.015386700630187988,
        "ground_truth": {
          "lymph node metastases": {
            "bertscore": 0.648277997970581,
            "f1": 0
          }
        }
      }
    }
  }
}